Scott Terrillion - Feb 8, 2024 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
SEC'Y; CHIEF COMPLIANCE & G.C.
Signature
/s/ Darren DeStefano, Attorney-in-Fact
Stock symbol
CARA
Transactions as of
Feb 8, 2024
Transactions value $
-$4,118
Form type
4
Date filed
2/12/2024, 05:16 PM
Previous filing
Feb 5, 2024
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale -$4.12K -7.77K -7.61% $0.53 94.3K Feb 8, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on September 7, 2018 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.